Increased activation of HDAC1, 2, and 6, and Sp1 underlies therapeutic resistance and tumor growth in glioblastoma

被引：1
|
作者：
Chuang, Jian-Ying [1 ]
Yang, Wen-Bin [1 ]
Hsu, Che-Chia [1 ]
机构：
[1] Taipei Med Univ, Taipei, Taiwan
来源：
FASEB JOURNAL | 2020年 / 34卷
关键词：
D O I：
10.1096/fasebj.2020.34.s1.02838
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Increased activation of HDAC1/2/6 and Sp1 underlies therapeutic resistance and tumor growth in glioblastoma
    Yang, Wen-Bin
    Hsu, Che-Chia
    Hsu, Tsung-, I
    Liou, Jing-Ping
    Chang, Kwang-Yu
    Chen, Pin-Yuan
    Liu, Jr-Jiun
    Yang, Shung-Tai
    Wang, Jia-Yi
    Yeh, Shiu-Hwa
    Chen, Ruei-Ming
    Chang, Wen-Chang
    Chuang, Jian-Ying
    NEURO-ONCOLOGY, 2020, 22 (10) : 1439 - 1451
  • [2] CD1d induction in solid tumor cells by histone deacetylase inhibitors through inhibition of HDAC1/2 and activation of Sp1
    Yang, Pei-Ming
    Lin, Pei-Jie
    Chen, Ching-Chow
    EPIGENETICS, 2012, 7 (04) : 390 - 399
  • [3] Overexpression of HDAC1 induces cellular senescence by Sp1/PP2A/pRb pathway
    Chuang, Jian-Ying
    Hung, Jan-Jong
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2011, 407 (03) : 587 - 592
  • [4] Induction of Synthetic Lethality by Activation of Mitochondrial ClpP and Inhibition of HDAC1/2 in Glioblastoma
    Nguyen, Trang T. T.
    Shang, Enyuan
    Schiffgens, Salveena
    Torrini, Consuelo
    Shu, Chang
    Akman, Hasan Orhan
    Prabhu, Varun V.
    Allen, Joshua E.
    Westhoff, Mike-Andrew
    Karpel-Massler, Georg
    Siegelin, Markus D.
    CLINICAL CANCER RESEARCH, 2022, 28 (09) : 1881 - 1895
  • [5] INDUCTION OF SYNTHETIC LETHALITY BY ACTIVATION OF MITOCHONDRIAL CLPP AND INHIBITION OF HDAC1/2 IN GLIOBLASTOMA
    Nguyen, Trang
    Shang, Enyuan
    Schiffgens, Salveena
    Torrini, Consuelo
    Bianchetti, Elena
    Shu, Chang
    Akman, Hasan Orhan
    Prabhu, Varun
    Allen, Joshua
    Westhoff, Mike-Andrew
    Karpel-Massler, Georg
    Siegelin, Markus D.
    NEURO-ONCOLOGY, 2021, 23 : 201 - 201
  • [6] Therapeutic effects of the Sp1 inhibitor mithramycin A in glioblastoma
    Seznec, Janina
    Silkenstedt, Bjoern
    Naumann, Ulrike
    JOURNAL OF NEURO-ONCOLOGY, 2011, 101 (03) : 365 - 377
  • [7] Therapeutic effects of the Sp1 inhibitor mithramycin A in glioblastoma
    Janina Seznec
    Björn Silkenstedt
    Ulrike Naumann
    Journal of Neuro-Oncology, 2011, 101 : 365 - 377
  • [8] ACTIVATION OF THE MITOCHONDRIAL CLPP PROTEASE IS SYNTHETICALLY LETHAL WITH HDAC1/2 INHIBITION IN GLIOBLASTOMA MODEL SYSTEMS
    Schiffgens, Salveena
    Trang Nguyen
    Shu, Chang
    Elena, Bianchetti
    Torrini, Consuelo
    Karpel-Massler, Georg
    Siegelin, Markus
    NEURO-ONCOLOGY, 2020, 22 : 98 - 98
  • [9] HDAC1 and HDAC6 are essential for driving growth in IDH1 mutant glioma
    Matthew C. Garrett
    Rebecca Albano
    Troy Carnwath
    Lubayna Elahi
    Catherine A. Behrmann
    Merissa Pemberton
    Daniel Woo
    Eric O’Brien
    Brett VanCauwenbergh
    John Perentesis
    Sanjit Shah
    Matthew Hagan
    Ady Kendler
    Chuntao Zhao
    Aditi Paranjpe
    Krishna Roskin
    Harley Kornblum
    David R. Plas
    Q. Richard Lu
    Scientific Reports, 13
  • [10] Stress stimuli induce cancer-sternness gene expression via Sp1 activation leading to therapeutic resistance in glioblastoma
    Chang, Kwang-Yu
    Huang, Chih-Ta
    Hsu, Tsung-I.
    Hsu, Che-Chia
    Liu, Jr-Jiun
    Chuang, Cheng-Keng
    Hung, Jan-Jong
    Chang, Wen-Chang
    Tsai, Kelvin K.
    Chuang, Jian-Ying
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2017, 493 (01) : 14 - 19
12345